Josh Haipeng Lei

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Breast Cancer Risk

Ischemia Reperfusion Injury

Radiofrequency Ablation

Top Venues

Science advances

Cancer research

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports (2024)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Xiaodong Shu, Jianjie Li, Un In Chan, Sek Man Su, Changxiang Shi, Xin Zhang, Tingting An, Jun Xu, Lihua Mo, Jianlin Liu, Yuqing Wang, Xiaoling Li, Chen Huang, Josh Haipeng Lei, Chunfei Wang, Hao Tian, Heng Sun, Joong Sup Shim, Xuanjun Zhang, Yulun Dai, Zhicheng Yao, Xiaying Kuang, Ying Lin, Chu-Xia Deng, Xiaoling Xu
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance. Cancer research (2023)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Josh Haipeng Lei, Mi-Hye Lee, Kai Miao, Zebin Huang, Zhicheng Yao, Aiping Zhang, Jun Xu, Ming Zhao, Zenan Huang, Xin Zhang, Si Chen, N G Jiaying, Yuzhao Feng, Fuqiang Xing, Ping Chen, Heng Sun, Qiang Chen, Tingxiu Xiang, Lin Chen, Xiaoling Xu, Chu-Xia Deng
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (21) (2021)